Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Mar 09,2016
Blood Test May Reveal Early Signs of Skin Cancer Relapse
    Skin cancer patients with advanced melanoma can take a sigh of relief. A new blood test developed by a team of researchers predicts the chances of relapse in patients.     Scientists from the Cancer Research UK Manchester Institute studied the DNA shed by tumors into the bloodstream (circulating tumor DNA) in blood samples from seven advancedRead more
More
Mar 09,2016
NAS Urges Rapid Learning System to Accelerate Personalized Medicine
    More rigor, insists the National Academy of Sciences (NAS), must be shown by practically everyone who is working on biomarker tests for molecularly targeted therapies. Through a report announced on March 4, "Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine,” the NAS is calling for "common evidentiary standards” and better coordination ofRead more
More
Mar 08,2016
Aim Immuno-Oncology at Trunk Antigens, Not Branch Antigens
    For all its genetic diversity, a tumor may yet display some common elements, antigens that reflect the tumor's early mutational history. If these common elements could be identified, they could be used to target practically all of the tumor's cells for destruction, and not just tumor cells that happen to display a relatively uncommon antigenRead more
More
Mar 08,2016
Rare Respiratory Disease Gene Carriers Actually Have Increased Lung Function
    New research has revealed the healthy carriers of a gene that causes a rare respiratory disease are taller and larger than average, with greater respiratory capacity.  Scientists from the University of Bristol report that rare respiratory disease gene carriers actually have increased lung function.     The disease, alpha1-antitrypsin deficiency (AATD) can result in severely reduced lungRead more
More
Mar 07,2016
New Kind of Stem Cell Discovered
    Scientists at Michigan State University have discovered a new kind of stem cell, one that could lead to advances in regenerative medicine as well as offer new ways to study birth defects and other reproductive problems.     “Other scientists may have seen these cells before, but they were considered to be defective, or cancer-like,” said Parenti,Read more
More
Mar 07,2016
Ancient Viral Invaders In Our DNA Help Fight Today Infections
    About eight percent of our DNA is viral in origin: remnants of ancient battles between infectious viruses and our ancestors. These so-called endogenous viruses are often perceived as a mere oddity with no clear biological significance. But a new study by scientists at the University of Utah, School of Medicine shows that evolution has repurposedRead more
More
Ancient Viral Invaders In Our DNA Help Fight Today Infections
Mar 04,2016
Advanced Immunotherapeutic Method Shows Promise against Brain Cancer
    Scientists from KU Leuven in Belgium say they have shown that next-generation cell-based immunotherapy may offer new hope in the fight against brain cancer.     Cell-based immunotherapy involves the injection of a therapeutic anticancer vaccine that stimulates the patient’s immune system to attack the tumor. Thus far, the results of this type of immunotherapy have beenRead more
More
Mar 04,2016
Broken Down Proteins vs Truncated Proteoforms
    If you see a shorter version of a protein, don't be too quick to dismiss it as a nonfunctional degradation product. It might be a shiny, new proteoform, an alternative version of a larger protein. The proteoform might even be more stable than the full-length protein. Although proteoforms may arise naturally as cells respond toRead more
More
Broken Down Proteins vs Truncated Proteoforms
Mar 03,2016
New Approach May Prevent and Reverse Fat Related Chronic Disease
    Researchers believe their work has led to a potential new weight control method that involves manipulating the production of fat cells at their source. Their study ("De Novo Generation of Adipocytes from Circulating Progenitor Cells in Mouse and Human Adipose Tissue”), published in the FASEB Journal, shows that at least some human fat cells areRead more
More
New Approach May Prevent and Reverse Fat Related Chronic Disease
Mar 03,2016
Study Links Normal Stem Cells To Aggressive Prostate Cancer
    A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer.     The study proved that the prostate basal cell layer contains adult stem cells, which possess a unique gene expression profile resembling the deadliest form of prostate cancer. The research was ledRead more
More
Study Links Normal Stem Cells To Aggressive Prostate Cancer
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->